Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T cell mitochondrial network and uptake machinery is a complex functional system responsible for the organization of mitochondria and the acquisition of these organelles from the extracellular environment to regulate T cell metabolic fitness and effector function. This machinery includes proteins governing mitochondrial dynamics, such as OPA1 and Mitofusins (Mfn1/2) for fusion and DRP1 for fission, as well as structures facilitating intercellular mitochondrial transfer, such as tunneling nanotubes (TNTs) and extracellular vesicles (EVs) [1, 4]. In the tumor microenvironment, this system is a critical mediator of immune evasion, as cancer cells can "hijack" mitochondria from infiltrating T cells through TNTs, leading to T cell metabolic depletion and exhaustion [1, 7]. Conversely, in inflammatory conditions like asthma, regulatory cells may transfer mitochondria to T cells to modulate their pro-inflammatory signaling [4, 6]. Therapeutic strategies targeting this machinery aim to either block the parasitic transfer of mitochondria to cancer cells or enhance the mitochondrial fitness of T cells in adoptive cell therapies, such as CAR-T, to improve their persistence and anti-tumor efficacy [1, 2].
Inhibition of mitochondrial fission via DRP1 blockade; disruption of tunneling nanotube (TNT) formation through farnesyltransferase inhibition; modulation of mitochondrial fusion and network integrity via OPA1/Mitofusin activation; inhibition of actin polymerization to prevent organelle transfer.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell mitochondrial network and uptake machinery.